DE69127029T2 - Verbessertes Verfahren zur Herstellung von 2-Amino(2,3,5-tri-O-benzyl-beta-d-arabinofuranosyl)adenin - Google Patents

Verbessertes Verfahren zur Herstellung von 2-Amino(2,3,5-tri-O-benzyl-beta-d-arabinofuranosyl)adenin

Info

Publication number
DE69127029T2
DE69127029T2 DE69127029T DE69127029T DE69127029T2 DE 69127029 T2 DE69127029 T2 DE 69127029T2 DE 69127029 T DE69127029 T DE 69127029T DE 69127029 T DE69127029 T DE 69127029T DE 69127029 T2 DE69127029 T2 DE 69127029T2
Authority
DE
Germany
Prior art keywords
tri
arabinofuranosyl
beta
benzyl
adenine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69127029T
Other languages
English (en)
Other versions
DE69127029D1 (de
Inventor
Anica Markovac
Maurice P Lamontagne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASH Stevens Inc
Original Assignee
ASH Stevens Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASH Stevens Inc filed Critical ASH Stevens Inc
Publication of DE69127029D1 publication Critical patent/DE69127029D1/de
Application granted granted Critical
Publication of DE69127029T2 publication Critical patent/DE69127029T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69127029T 1990-06-15 1991-05-14 Verbessertes Verfahren zur Herstellung von 2-Amino(2,3,5-tri-O-benzyl-beta-d-arabinofuranosyl)adenin Expired - Fee Related DE69127029T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/538,661 US5206351A (en) 1990-06-15 1990-06-15 Process for the preparation of 2-amino (2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenine

Publications (2)

Publication Number Publication Date
DE69127029D1 DE69127029D1 (de) 1997-09-04
DE69127029T2 true DE69127029T2 (de) 1997-11-13

Family

ID=24147882

Family Applications (2)

Application Number Title Priority Date Filing Date
DE199191107780T Pending DE461407T1 (de) 1990-06-15 1991-05-14 Verbessertes verfahren zur herstellung von 2-amino(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenin.
DE69127029T Expired - Fee Related DE69127029T2 (de) 1990-06-15 1991-05-14 Verbessertes Verfahren zur Herstellung von 2-Amino(2,3,5-tri-O-benzyl-beta-d-arabinofuranosyl)adenin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE199191107780T Pending DE461407T1 (de) 1990-06-15 1991-05-14 Verbessertes verfahren zur herstellung von 2-amino(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenin.

Country Status (7)

Country Link
US (1) US5206351A (de)
EP (1) EP0461407B1 (de)
JP (1) JPH0733394B2 (de)
AT (1) ATE156131T1 (de)
DE (2) DE461407T1 (de)
ES (1) ES2042436T1 (de)
GR (1) GR920300049T1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
US7528247B2 (en) * 2001-08-02 2009-05-05 Genzyme Corporation Process for preparing purine nucleosides
DE60226447D1 (de) * 2001-08-02 2008-06-19 Ilex Oncology Inc Verfahren zur herstellung von purinnukleosiden

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287188A (en) * 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
JPS5741314Y2 (de) * 1977-07-30 1982-09-10
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
JPS62116582A (ja) * 1985-09-24 1987-05-28 ヘキスト・アクチエンゲゼルシヤフト 6−および9−位が置換された2−アミノプリン
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds

Also Published As

Publication number Publication date
DE461407T1 (de) 1992-06-11
GR920300049T1 (en) 1992-08-26
JPH0733394B2 (ja) 1995-04-12
DE69127029D1 (de) 1997-09-04
JPH0665281A (ja) 1994-03-08
EP0461407B1 (de) 1997-07-30
US5206351A (en) 1993-04-27
ATE156131T1 (de) 1997-08-15
ES2042436T1 (es) 1993-12-16
EP0461407A1 (de) 1991-12-18

Similar Documents

Publication Publication Date Title
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
ES2177555T3 (es) Octaciclodepsipeptidos con actividad endoparasiticida.
ATE89823T1 (de) Verfahren zur herstellung von baccatin-iiiderivaten und von desacetyl-10-baccatin-iii.
DE69131967D1 (de) Verfahren zur Herstellung von 1,1-Diarylprolinolen
DE3882452T2 (de) Verfahren zur Herstellung von Gegenständen aus Kohlenstoff/Kohlenstoffasern.
DE68916086T2 (de) Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
DE69021711D1 (de) Verfahren zur Herstellung von optisch aktiven Hydroxylactonen.
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
DE59105577D1 (de) Verfahren zur Herstellung von Arylcarbonaten.
DE69017830D1 (de) Verfahren zur Herstellung von aliphatischen Isozyanaten.
DE69127029T2 (de) Verbessertes Verfahren zur Herstellung von 2-Amino(2,3,5-tri-O-benzyl-beta-d-arabinofuranosyl)adenin
DE69228434D1 (de) Verfahren zur Herstellung von Urethangruppen enthaltende Bisoxazolidinen
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DE69110711T2 (de) Verfahren zur Herstellung von Polyolefine.
NO178231C (no) Umettede polyesterharpiksblandinger og anvendelse av disse
DE59309002D1 (de) Verfahren zur Herstellung von 6-Chlor-(6H)-dibenz-(c,e)(1,2)-oxaphosphorin
DE59010027D1 (de) Verfahren zur diskontinuierlichen Herstellung von L-Carnitin auf mikrobiologischem Weg
DE68915067T2 (de) Verfahren zur Herstellung von 2'-Deoxy-beta-adenosin.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
DE69107897T2 (de) Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid).
DE69114742D1 (de) Verfahren zur Herstellung von Fluoromethyl substituierten Pyridin-Carbodithioaten.
DE59106016D1 (de) Verfahren zur Herstellung von 2,3-Dihydrobenzofuranen.
ATE93832T1 (de) Verfahren zur herstellung von 4,6-dimethyl-7hydroxynonan-3-on.
DE69110734D1 (de) Verfahren zur Herstellung von hexamethylcyclotrisilazan.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee